Bioequivalence study of GZR18 injection
Part of Hormones & metabolism clinical trials.
This study tests whether a change in the manufacturing process for GZR18 (an experimental injectable drug) affects how it works in the body. It may help determine if the new version is as safe and effective as the original.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Men aged 18 to 50.
- Weight at least 110 pounds (50 kg) with a body mass index between 19 and 26.
- Willing to use effective birth control and not donate sperm for 8 weeks after the last dose.
- No history of pancreatitis, certain thyroid cancers, or severe allergies to similar drugs.
- No use of certain medications or vaccines within weeks before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new injection works the same as the approved version in overweight or obese adults. It may help if you are looking for a weight management treatment.
This trial tests a new injection (GZR102) compared to two other injections (GZR4 and GZR18) in overweight adults. The goal is to see how well the body processes each drug and their effects. It may help researchers find a better treatment for weight management.
This study tests if a new insulin injection made with different manufacturing methods works the same in the body. Healthy men aged 18-50 can join to help check if the new versions are as good as the original.
This trial tests how a new drug called GZR18 (given as an injection) affects the body in people with different levels of kidney function. It aims to find the right dose and check for side effects, which could help guide treatment for people with kidney issues.
This study tests a new drug called GZR18 to see how it works in people with different levels of liver function. It aims to help find the right dose and check safety.
This trial tests how a new injectable drug, GZR18, affects how fast your stomach empties and how it interacts with other medicines. It is for obese Chinese adults who want to join a research study.
Hear when a new Obesity&T2D trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.